What You Should Know:
– Proscia, a provider of AI-powered pathology solutions, is accelerating the pace of drug discovery and diagnostic development with the launch of Concentriq® Embeddings and the Proscia AI Toolkit.
– These powerful…
Continue Reading
Introduction
In recent years, advancements in technology have significantly impacted cancer research and drug discovery. One of the most exciting developments is the collaboration between MedTech startup Imagene AI and Oracle, which leverages artificial intelligence…
Researchers at King’s College London and Imperial College London have developed an AI algorithm that could help aid drug discovery.
The computer-based tool, named Drug Synthesis using Monte Carlo (DrugSynthMC), expands the diversity within drug…
The following is a guest article by Kenji Taylor, MD, MSc, Clinical Consultant, Supervising Physician at Ubie
Artificial intelligence holds immense potential to revolutionize healthcare, offering precision medicine, accelerated drug discovery, and improved patient outcomes….
What You Should Know:
– Gilead Sciences, a global biopharmaceutical company, and Genesis Therapeutics, an AI-focused biotechnology firm, have announced a strategic collaboration to discover and develop innovative small molecule therapies.
– The startegic partnership leverages…
Continue Reading
In the rapidly evolving world of pharmaceuticals, artificial intelligence (AI) is emerging as a game-changer. From accelerating drug discovery to enhancing the efficiency of clinical trials, AI is revolutionizing how new medicines are brought…
Continue Reading
What You Should Know:
– Quantiphi, an AI-first digital engineering company, announced a strategic minority investment in Transcell, a pioneering stem cell-based biotech innovator. This collaboration marks a significant step forward in the integration of…
Continue Reading
What You Should Know: – Absci Corporation, a leader in generative AI drug creation, today announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop up to six novel cancer therapeutics. …
Continue Reading
Cleveland Clinic and the Novo Nordisk Foundation have announced a new academic partnership focusing on leading-edge IT research and its clinical applications. The three-year opportunity is aimed at early-stage researchers working at the intersection…
Continue Reading
What You Should Know: –Genomics plc (Genomics), a healthcare company transforming health through the power of genomics today announced a three-year extension of the company’s collaboration with Vertex Pharmaceuticals Incorporated (Vertex) (Nasdaq: VRTX) to…
Continue Reading
